Chemical Marker Reporter October 13, 2015 ferghanaadmin Press Release “SCHERING AG; acquired rights for Refludan” Related Posts Daktari Diagnostics “Closes Series D Funding Round” Mina Therapeutics "Agreement to Develop Novel Treatment Approaches for Fibrotic Liver Diseases" Anteo Diagnostics “Acquires DIAsource ImmunoAssays”